Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Diabetes, Depression, and Dementia Link
Hyperglycemia & the Link Between Diabetes and COVID-19 Deaths
Letter from the Editor
Leyany Feijoo Ramos, PharmD Candidate, LECOM School of Pharmacy, is considering a residency in infectious medicine, which would put her in the forefront of COVID-19 research and treatment. She recently put together an overview of how diabetes and increased glucose levels in non-diagnosed diabetes patients can increase the patients’ chances of dying from an infection.
The information she is sharing will make you think twice about giving a patient time to fix their glucose before you begin aggressive therapy.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: Diabetes + Covid = Increased Risk for DEATH
See this week’s Fact.
TOP STORIES — Diabetes News and Research
The diagnosis and treatment of depression in the elderly population with type 2 diabetes are essential for managing dementia risks.
Even patients without diabetes may be at a higher risk for complications and mortality if their blood glucose is elevated.
Many adults with type 2 diabetes carry the burden of complicated medication regimens, associated with worse patient outcomes and a higher potential for drug interactions.
Fact: 20% of Diabetes Patients With COVID-19 May Die
A study in Diabetologia found that 20% of patients died within 28 days of being admitted to a hospital. Based on data from roughly 2,800 adults, the findings also revealed that elevated blood glucose level at the time of hospital admission was a strong predictor of lower odds of discharge and a higher risk of death. The patients’ mean age was 70, nearly two-thirds were men, and many were overweight. About 40% were also experiencing various forms of complications from their diabetes. Routine treatment by insulin and statin were cited as deleterious factors, while younger age, routine metformin therapy and longer symptom duration on admission were positively associated with discharge. Of those patients who survived at least one month, 50% were discharged from the hospital with a median stay of nine days; 12% were still hospitalized on day 28, and 17% had been transferred from their first hospital to another facility.
Mangala Narasimhan, Diabetologia, news release, Feb. 17, 2021
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Alexandria Bartley, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences
Eric Cheung, PharmD Candidate, USF Taneja College of Pharmacy
Zahra Hashemy, PharmD. Candidate, USF Taneja College of Pharmacy
Laura Martínez López, PharmD. Candidate 2021, Lake Erie College of Osteopathic Medicine, College of Pharmacy
Leyany Feijoo Ramos, PharmD. Candidate, LECOM School of Pharmacy
Stephen Rubano, PharmD. Candidate, USF Taneja College of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com